TTY Biopharm Company Limited

About TTY About TTY
Strategic Deployment

About Strategic Deployment

Global Operations

TTY Group

Management

Corporate Executives

Organization

Collaboration and Services

Licensing

Contract Development Manufacturing

PIC/S GMP Business Service

Distribution

Newsroom
Technology Development Technology Development
Liposomes

Introduction

Pipeline

Microspheres

Introduction

Pipeline

Conventional Products

Introduction

Dosage Form

Formulation Capabilities

Formulation Development

Analytical Development

Process Development

Animal Studies

Functional Excipents

GMP Manufacturing

CMC Preparation
Manufacturing Manufacturing
Cytotoxic Products

Non-cytotoxic Products
Product Areas Product Areas
Oncology

Products

About TOT

Anti-Infection

Products

About TIT

Healthcare

Products

About KAM
Investors Investors
Investor Conference

Financials

Monthly Revenues

Financial Statements

Annual Report

Shareholder Services

Dividends

Shareholder's Meeting

List of Major Shareholders

Corporate Governance

Board of Directors

Sustainable Development Committee

Audit Committee

Remuneration Committee

Major Corporate Policies

Internal Audit

IP Management

Information Security
Careers Careers
Philosophy

Workplace Happiness

Attractive salary

Excellent benefits

Amicable environment

Positive activities

TTY Seeds

New Comer Socialization

Talent Development Program (TDP)

Join TTY

Professional challenges

Recruitment process

Transportation ways

Industry Academy Cooperation
Sustainability Sustainability
Sustainability Report

Download

TCFD

SASB

Governance

Environmental

Energy & GHG Emission

Water Management

Air Pollution Control

Waste Management

Toxicity Management

TTY Actions

Social

Cancer Cares

Love for Society

TTY Rice

Awards

Employee Care

Salary & Benefits

Comprehensive Training

Occupational Safety & Health

Epidemic Prevention

Supplier

Supplier Assessment

Cold Chain Management

Contractor Management

En /
繁中

Home
About TTY
Newsroom

PharmaEngine Announces MM-398 (PEP02) in Combination with 5-FU/LV Result

PharmaEngine Announces MM-398 (PEP02) in Combination with 5-FU/LV Result

2014.5.1 最新消息

...

_«
«
11
12
»
»_

MOPS

If you want to know more information, you can link to MOPS. (Stock Code: 4105)

TTY Material Information

Contact Us

More information or suggestions, please contact us by:

Email： info@tty.com.tw

Tel： +886-2-26525999

Sitemap
Terms of use
Privacy
Questionnaire to Stakeholders
Contact us

Copyright © 2018 . All rights reserved.

^TOP